We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Ovarian Reserve Tests Prove Poor Predictors of Fertility

By LabMedica International staff writers
Posted on 24 Oct 2017
Print article
Image: A positive pregnancy test; Women with test results indicating low ovarian reserve were no less likely to conceive within six or 12 months of attempts than women whose laboratory tests did not point to a limited egg supply (Photo courtesy of News Health Advisor).
Image: A positive pregnancy test; Women with test results indicating low ovarian reserve were no less likely to conceive within six or 12 months of attempts than women whose laboratory tests did not point to a limited egg supply (Photo courtesy of News Health Advisor).
Tests that measure a woman’s “ovarian reserve” to estimate how many more years of fertility she has have grown increasingly popular, yet despite the lack of evidence of their utility, biomarkers of ovarian reserve are being promoted as potential markers of reproductive potential.

Previous studies have correlated levels of the three hormones with the number of eggs a woman has in her ovaries, known as a measure known as “ovarian reserve.” Studies have suggested that information could be used to predict how well a woman will respond to in vitro fertilization. But in recent years, as more women are delaying pregnancy until later ages, ovarian reserve tests have begun to be used as a way to test for future fertility.

Medical Scientists at the University of North Carolina, (Chapel Hill, NC, USA) carried out a prospective time-to-pregnancy cohort study (2008 to date of last follow-up in March 2016) of 981 women aged 30 to 44 years without a history of infertility who had been trying to conceive for three months or less, recruited from the local community. Their mean age was 33.3 ± 3.2 years; 77% were white; and 36% were overweight or obese. The primary outcomes were the cumulative probability of conception by six and 12 cycles of attempt and relative fecundability (probability of conception in a given menstrual cycle). Conception was defined as a positive pregnancy test result.

The scientists looked the early-follicular-phase serum level of antimüllerian hormone (AMH), follicle-stimulating hormone (FSH), and inhibin B and urinary level of FSH. They found that after adjusting for age, body mass index, race, current smoking status, and recent hormonal contraceptive use, 84 women with low AMH values of less than 0.7 ng/mL did not have a significantly different predicted probability of conceiving by six cycles of attempt (65%) compared with 579 women with normal values (62%) or by 12 cycles of attempt (84% versus 75% respectively). The 83 women with high serum FSH values of greater than 10 mIU/mL did not have a significantly different predicted probability of conceiving after six cycles of attempt compared with 654 women with normal values. Similarly, women with high urinary FSH values of greater than 11.5 mIU/mg creatinine did not have a significantly different predicted probability of conceiving and Inhibin B levels were not associated with the probability of conceiving in a given cycle.

The authors concluded that among women aged 30 to 44 years without a history of infertility who had been trying to conceive for three months or less, biomarkers indicating diminished ovarian reserve compared with normal ovarian reserve were not associated with reduced fertility. The study was published on October 10, 2017, in the Journal of the American Medical Association.

Related Links:
University of North Carolina

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: The new method could reduce undiagnosed cancer cases in less-developed regions (Photo courtesy of 123RF)

New Method Offers Sustainable Approach to Universal Metabolic Cancer Diagnosis

Globally, more than one billion people suffer from a high rate of missed disease diagnosis, highlighting the urgent need for more precise and affordable diagnostic tools. Such tools are especially crucial... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.